Infection in cystic fibrosis: impact of the environment and climate

References

• O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–1904.
   PubMed Web of Science ®Google Scholar
• Bell SC, De Boeck K, Amaral MD. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol Ther. 2015;145:19–34.
   PubMed Web of Science ®Google Scholar
• Zolin AM, McKone EF, van Rens J. et al. European Cystic Fibrosis Patient Registry Annual Data Report 2010. 2014. [cited 2015 Aug 28]. Available from: www.ecfs.eu/projects/ecfs-patient-registry/annual-reports
   Google Scholar
• UK CF Registry annual data report 2013. London (UK): © Cystic Fibrosis Trust; 2014. [cited 2015 Aug 28]. Available from: www.cysticfibrosis.org.uk/research-care/uk-cf-registry/cf-registry-reports
   Google Scholar
• The Canadian cystic fibrosis registry 2012 annual report. Toronto (Ontario): Cystic Fibrosis Canada; 2014. [cited 2015 Aug 28]. Available from: www.cysticfibrosis.ca/news-and-media/publications/
   Google Scholar
• Cystic fibrosis Australia 2013 16th annual report from the cystic fibrosis data registry. Sydney (Australia): Cystic Fibrosis Australia; 2015. [cited 2015 Aug 28]. Available from: www.cysticfibrosis.org.au/data-registry
   Google Scholar
• Burgel PR, Bellis G, Olesen HV, et al. Future trends in cystic fibrosis demography in 34 European countries. Eur Respir J. 2015;46(1):133–141.
   PubMed Web of Science ®Google Scholar
• Cystic Fibrosis Foundation Patient Registry 2014 Annual Data Report to the Center Directors. Bethesda, Maryland: © Cystic Fibrosis Foundation. 2015. [cited 2015 Aug 28]. Available from: www.cff.org/Our-Research/CF-Patient-Registry/
   Google Scholar
• Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001;183(3):444–452.
   PubMed Web of Science ®Google Scholar
• MacKenzie T, Gifford AH, Sabadosa KA, et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry. Ann Intern Med. 2014;161(4):233–241.
   PubMed Web of Science ®Google Scholar
• Flume PA, Strange C, Ye X, et al. Pneumothorax in cystic fibrosis. Chest. 2005;128(2):720–728.
   PubMed Web of Science ®Google Scholar
• Flume PA, Yankaskas JR, Ebeling M, et al. Massive hemoptysis in cystic fibrosis. Chest. 2005;128(2):729–738.
   PubMed Web of Science ®Google Scholar
• Plant BJ, Goss CH, Plant WD, et al. Management of comorbidities in older patients with cystic fibrosis. Lancet Respir Med. 2013;1(2):164–174.
   PubMed Web of Science ®Google Scholar
• Rabin HR, Butler SM, Wohl ME, et al. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol. 2004;37(5):400–406.
   PubMed Web of Science ®Google Scholar
• Bell SC, Reid DW. Challenges of the care of adults with cystic fibrosis. ERJ Monograph. 2014;64:287–304.
   Google Scholar
• Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros. 2015;14(3):293–304.
   PubMed Web of Science ®Google Scholar
• Hirche TO, Bradley J, d’Alquen D, et al. Travelling with cystic fibrosis: recommendations for patients and care team members. J Cyst Fibros. 2010;9(6):385–399.
   PubMed Web of Science ®Google Scholar
• Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23(2):299–323.
   PubMed Web of Science ®Google Scholar
• Bar-On O, Mussaffi H, Mei-Zahav M, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros. 2015;14(1):53–62.
   PubMed Web of Science ®Google Scholar
• Qvist T, Gilljam M, Jonsson B, et al. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros. 2015;14(1):46–52.
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Whiley DM, Bell SC, et al. Pseudomonas. In: Liu D, editor. Molecular detection of human bacterial pathogens. Boca Raton (FL): CRC Press, Taylor and Francis Group; 2001. p. 1009–1022.
   Google Scholar
• Anaissie EJ, Penzak SR, Dignani MC. The hospital water supply as a source of nosocomial infections: a plea for action. Arch Intern Med. 2002;162(13):1483–1492.
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Ritchie SR, Ramsay KA, et al. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One. 2012;7(9):e44199.
   PubMed Web of Science ®Google Scholar
• Ogbulie JN, Adieze IE, Nwankwo NC. Susceptibility pattern of some clinical bacterial isolates to selected antibiotics and disinfectants. Pol J Microbiol. 2008;57(3):199–204.
   PubMed Web of Science ®Google Scholar
• Pirnay JP, Matthijs S, Colak H, et al. Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river. Environ Microbiol. 2005;7(7):969–980.
   PubMed Web of Science ®Google Scholar
• Remold SK, Brown CK, Farris JE, et al. Differential habitat use and niche partitioning by Pseudomonas species in human homes. Microb Ecol. 2011;62(3):505–517.
   PubMed Web of Science ®Google Scholar
• Pirnay JP, Bilocq F, Pot B, et al. Pseudomonas aeruginosa population structure revisited. PLoS One. 2009;4(11):e7740.
   PubMed Web of Science ®Google Scholar
• Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. 2002;112(7 Pt 1):1166–1177.
   PubMed Web of Science ®Google Scholar
• Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27(1):22–27.
   PubMed Web of Science ®Google Scholar
• Stapleton F, Keay LJ, Sanfilippo PG, et al. Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia. Am J Ophthalmol. 2007;144(5):690–698.
   PubMed Web of Science ®Google Scholar
• Perencevich EN, McGregor JC, Shardell M, et al. Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol. 2008;29(12):1124–1131.
   PubMed Web of Science ®Google Scholar
• Tucker P, Gilliland J. The effect of season and weather on physical activity: a systematic review. Public Health. 2007;121(12):909–922.
   PubMed Web of Science ®Google Scholar
• Cappello S, Guglielmino SPP. Effects of growth temperature on polystyrene adhesion of Pseudomonas aeruginosa ATCC 27853. Braz J Microbiol. 2006;37(3):205–207.
   Web of Science ®Google Scholar
• Hostacka A, Ciznar I, Stefkovicova M. Temperature and pH affect the production of bacterial biofilm. Folia Microbiol (Praha). 2010;55(1):75–78.
   PubMed Web of Science ®Google Scholar
• Abdallah M, Benoliel C, Ferreira-Theret P, et al. Effect of culture conditions on the resistance of Pseudomonas aeruginosa biofilms to disinfecting agents. Biofouling. 2015;31(1):49–59.
   PubMed Web of Science ®Google Scholar
• Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs. 2007;67(3):351–368.
   PubMed Web of Science ®Google Scholar
• Llanes C, Pourcel C, Richardot C, et al. Diversity of beta-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. J Antimicrob Chemother. 2013;68(8):1763–1771.
   PubMed Web of Science ®Google Scholar
• Hogardt M, Heesemann J. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr Top Microbiol Immunol. 2013;358:91–118.
   PubMed Web of Science ®Google Scholar
• Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91–100.
   PubMed Web of Science ®Google Scholar
• Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918–951.
   PubMed Web of Science ®Google Scholar
• Cystic Fibrosis Foundation Patient Registry 2013 Annual Data Report to the Center Directors. Bethesda, Maryland: © Cystic Fibrosis Foundation. 2014. [cited 2015 Aug 28]. Available from: www.cff.org/Our-Research/CF-Patient-Registry/
   Google Scholar
• Hansen CR, Pressler T, Hoiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros. 2008;7(6):523–530.
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Ramsay KA, Vidmar S, et al. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. J Cyst Fibros. 2015;14(3):361–369.
   PubMed Web of Science ®Google Scholar
• Ranganathan SC, Skoric B, Ramsay KA, et al. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ann Am Thorac Soc. 2013;10(2):108–114.
   PubMedGoogle Scholar
• Kidd TJ, Ramsay KA, Hu H, et al. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J. 2013;41(5):1091–1100.
   PubMed Web of Science ®Google Scholar
• Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J. 2012;40(1):227–238.
   PubMed Web of Science ®Google Scholar
• Jones AM, Govan JR, Doherty CJ, et al. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax. 2003;58(6):525–527.
   PubMed Web of Science ®Google Scholar
• Knibbs LD, Johnson GR, Kidd TJ, et al. Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax. 2014;69(8):740–745.
   PubMed Web of Science ®Google Scholar
• Johansen HK, Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax. 1992;47(2):109–111.
   PubMed Web of Science ®Google Scholar
• Psoter KJ, De Roos AJ, Wakefield J, et al. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect. 2013;19(11):E483–E489.
   PubMed Web of Science ®Google Scholar
• Collaco JM, McGready J, Green DM, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One. 2011;6(11):e27784.
   PubMed Web of Science ®Google Scholar
• Psoter KJ, Der AJ, Wakefield J, et al. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Epidemiol Infect. 2016;144(5):1075–1083.
   PubMed Web of Science ®Google Scholar
• Kopp BT, Nicholson L, Paul G, et al. Geographic variations in cystic fibrosis: an analysis of the U.S. CF Foundation Registry. Pediatr Pulmonol. 2015;50(8):754–762.
   PubMed Web of Science ®Google Scholar
• Psoter KJ, Rosenfeld M, De Roos AJ, et al. Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis. Am J Epidemiol. 2014;179(12):1503–1513.
   PubMed Web of Science ®Google Scholar
• Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32(4):277–287.
   PubMed Web of Science ®Google Scholar
• Purdy-Gibson ME, France M, Hundley TC, et al. Pseudomonas aeruginosa in CF and non-CF homes is found predominantly in drains. J Cyst Fibros. 2015;14(3):341–346.
   PubMed Web of Science ®Google Scholar
• Rosenfeld M, Emerson J, McNamara S, et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros. 2012;11(5):446–453.
   PubMed Web of Science ®Google Scholar
• Goeminne PC, Nawrot TS, De Boeck K, et al. Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: a case-control analysis. J Cyst Fibros. 2015;14(6):741–747.
   PubMed Web of Science ®Google Scholar
• Coenye T, Vandamme P. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol. 2003;5(9):719–729.
   PubMed Web of Science ®Google Scholar
• Compant S, Nowak J, Coenye T, et al. Diversity and occurrence of Burkholderia spp. in the natural environment. FEMS Microbiol Rev. 2008;32(4):607–626.
   PubMed Web of Science ®Google Scholar
• Coenye T, Laevens S, Willems A, et al. Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples. Int J Syst Evol Microbiol. 2001;51(Pt 3):1099–1107.
   PubMed Web of Science ®Google Scholar
• O’Carroll MR, Kidd TJ, Coulter C, et al. Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis. Thorax. 2004;58(12):1087–1091.
   Web of Science ®Google Scholar
• Zlosnik JE, Zhou G, Brant R, et al. Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years’ experience. Ann Am Thorac Soc. 2015;12(1):70–78.
   PubMedGoogle Scholar
• Geake JB, Reid DW, Currie BJ, et al. An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulm Med. 2015;15:116.
   PubMed Web of Science ®Google Scholar
• Smet B, Mayo M, Peeters C, et al. Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. Int J Syst Evol Microbiol. 2015;65:2265–2271.
   PubMed Web of Science ®Google Scholar
• Ramsay KA, Butler CA, Paynter S, et al. Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. J Clin Microbiol. 2013;51(12):3975–3980.
   PubMed Web of Science ®Google Scholar
• LiPuma JJ. Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med. 2003;24(6):681–692.
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Douglas JM, Bergh HA, et al. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. Res Microbiol. 2008;159(3):194–199.
   PubMed Web of Science ®Google Scholar
• Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med. 2015;36(1):111–125.
   PubMed Web of Science ®Google Scholar
• Inglis TJ, Sagripanti JL. Environmental factors that affect the survival and persistence of Burkholderia pseudomallei. Appl Environ Microbiol. 2006;72(11):6865–6875.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012;367(11):1035–1044.
   PubMed Web of Science ®Google Scholar
• Sun H, Shi B, Bai Y, et al. Bacterial community of biofilms developed under different water supply conditions in a distribution system. Sci Total Environ. 2014;472:99–107.
   PubMed Web of Science ®Google Scholar
• Amoureux L, Bador J, Fardeheb S, et al. Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates. Appl Environ Microbiol. 2013;79(23):7142–7149.
   PubMed Web of Science ®Google Scholar
• Ridderberg W, Bendstrup KE, Olesen HV, et al. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. J Cyst Fibros. 2011;10(6):466–469.
   PubMed Web of Science ®Google Scholar
• Wittmann J, Dreiseikelmann B, Rohde C, et al. Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans. PLoS One. 2014;9(1):e86935.
   PubMed Web of Science ®Google Scholar
• Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.
   PubMed Web of Science ®Google Scholar
• van der Wielen PW, Van Der Kooij D. Nontuberculous mycobacteria, fungi, and opportunistic pathogens in unchlorinated drinking water in The Netherlands. Appl Environ Microbiol. 2013;79(3):825–834.
   PubMed Web of Science ®Google Scholar
• De Baets F, Schelstraete P, Van Daele S, et al. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros. 2007;6(1):75–78.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Pressler T, Nielsen KG, et al. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros. 2010;9(1):51–58.
   PubMed Web of Science ®Google Scholar
• Lambiase A, Catania MR, Del Pezzo M, et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 2011;30(8):973–980.
   PubMed Web of Science ®Google Scholar
• Goss CH, Mayer-Hamblett N, Aitken ML, et al. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax. 2004;59(11):955–959.
   PubMed Web of Science ®Google Scholar
• Waters V, Atenafu EG, Lu A, et al. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J Cyst Fibros. 2013;12(5):482–486.
   PubMed Web of Science ®Google Scholar
• Waters V, Yau Y, Prasad S, et al. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Respir Crit Care Med. 2011;183(5):635–640.
   PubMed Web of Science ®Google Scholar
• Festini F, Taccetti G, Mannini C, et al. Patient risk of contact with respiratory pathogens from inanimate surfaces in a cystic fibrosis outpatient clinic. A prospective study over a four-year period. Pediatr Pulmonol. 2007;42(9):779–784.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Pressler T, Ridderberg W, et al. Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contact. J Cyst Fibros. 2013;12(6):609–615.
   PubMed Web of Science ®Google Scholar
• Kanellopoulou M, Pournaras S, Iglezos H, et al. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis. 2004;23(4):336–339.
   PubMed Web of Science ®Google Scholar
• Van Daele S, Verhelst R, Claeys G, et al. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J Clin Microbiol. 2005;43(6):2998–3002.
   PubMed Web of Science ®Google Scholar
• Brooke JS, Annand JW, Hammer A, et al. Investigation of bacterial pathogens on 70 frequently used environmental surfaces in a large urban U.S. university. J Environ Health. 2009;71(6):17–22.
   PubMed Web of Science ®Google Scholar
• Schable B, Villarino ME, Favero MS, et al. Application of Multilocus enzyme electrophoresis to epidemiologic investigations of Xanthomonas maltophilia. Infect Control Hosp Epidemiol. 1991;12(3):163–167.
   PubMed Web of Science ®Google Scholar
• Nicoletti M, Iacobino A, Prosseda G, et al. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol. 2011;301(1):34–43.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Pomponio S, Crocetta V, et al. Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. BMC Microbiol. 2011;11:159.
   PubMed Web of Science ®Google Scholar
• King P. Haemophilus influenzae and the lung (Haemophilus and the lung). Clin Transl Med. 2012;1(1):10.
   PubMedGoogle Scholar
• Rubach MP, Bender JM, Mottice S, et al. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis. 2011;17(9):1645–1650.
   PubMed Web of Science ®Google Scholar
• Sollid JU, Furberg AS, Hanssen AM, et al. Staphylococcus aureus: determinants of human carriage. Infect Genet Evol. 2014;21:531–541.
   PubMed Web of Science ®Google Scholar
• Korzeniewski K, Nitsch-Osuch A, Lass A, et al. Respiratory infections in travelers returning from the tropics. Adv Exp Med Biol. 2015;849:75–82.
   PubMed Web of Science ®Google Scholar
• Britton PN, Andresen DN. Paediatric community-associated Staphylococcus aureus: a retrospective cohort study. J Paediatr Child Health. 2013;49(9):754–759.
   PubMed Web of Science ®Google Scholar
• Glikman D, Siegel JD, David MZ, et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S. aureus. Chest. 2008;133(6):1381–1387.
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Coulter C, Bell SC. Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis. Infect Control Hosp Epidemiol. 2006;27(2):201–203.
   PubMed Web of Science ®Google Scholar
• Muhlebach MS, Miller M, LaVange LM, et al. Treatment intensity and characteristics of MRSA infection in CF. J Cyst Fibros. 2011;10(3):201–206.
   PubMed Web of Science ®Google Scholar
• Besier S, Zander J, Kahl BC, et al. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2008;52(6):2183–2189.
   PubMed Web of Science ®Google Scholar
• Morelli P, De Alessandri A, Manno G, et al. Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre. New Microbiol. 2015;38(2):235–243.
   PubMed Web of Science ®Google Scholar
• Wolter DJ, Emerson JC, McNamara S, et al. Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis. 2013;57(3):384–391.
   PubMed Web of Science ®Google Scholar
• Frei CR, Makos BR, Daniels KR, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg. 2010;45(10):1967–1974.
   PubMed Web of Science ®Google Scholar
• Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am. 1959;43(1):273–290.
   PubMed Web of Science ®Google Scholar
• Falkinham JO. Impact of human activities on the ecology of nontuberculous mycobacteria. Future Microbiol. 2010;5(6):951–960.
   PubMed Web of Science ®Google Scholar
• Falkinham JO 3rd. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol. 2009;107(2):356–367.
   PubMed Web of Science ®Google Scholar
• Thomson RM. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010;16(10):1576–1583.
   PubMed Web of Science ®Google Scholar
• Adjemian J, Olivier KN, Seitz AE, et al. Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881–886.
   PubMed Web of Science ®Google Scholar
• Chou MP, Clements AC, Thomson RM. A spatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia. BMC Infect Dis. 2014;14:279.
   PubMed Web of Science ®Google Scholar
• Adjemian J, Olivier KN, Seitz AE, et al. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med. 2012;186(6):553–558.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Iwai K, Uchimura K, et al. A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc. 2014;11(1):1–8.
   PubMedGoogle Scholar
• Thomson RM, Carter R, Tolson C, et al. Factors associated with the isolation of nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia. BMC Microbiol. 2013;13:89.
   PubMed Web of Science ®Google Scholar
• Falkinham JO 3rd. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis. 2011;17(3):419–424.
   PubMed Web of Science ®Google Scholar
• Esther CR Jr., Esserman DA, Gilligan P, et al. Chronic mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros. 2010;9(2):117–123.
   PubMed Web of Science ®Google Scholar
• Prevots DR, Adjemian J, Fernandez AG, et al. Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population. Ann Am Thorac Soc. 2014;11(7):1032–1038.
   PubMedGoogle Scholar
• Benedict K, Park BJ. Invasive fungal infections after natural disasters. Emerg Infect Dis. 2014;20(3):349–355.
   PubMed Web of Science ®Google Scholar
• Frankel M, Beko G, Timm M, et al. Seasonal variations of indoor microbial exposures and their relation to temperature, relative humidity, and air exchange rate. Appl Environ Microbiol. 2012;78(23):8289–8297.
   PubMed Web of Science ®Google Scholar
• Grinn-Gofron A, Strzelczak A. Changes in concentration of alternaria and cladosporium spores during summer storms. Int J Biometeorol. 2013;57(5):759–768.
   PubMed Web of Science ®Google Scholar
• Oliveira M, Ribeiro H, Delgado L, et al. Outdoor allergenic fungal spores: comparison between an urban and a rural area in northern Portugal. J Investig Allergol Clin Immunol. 2010;20(2):117–128.
   PubMed Web of Science ®Google Scholar
• Barberan A, Ladau J, Leff JW. Continental-scale distributions of dust-associated bacteria and fungi. Proc Natl Acad Sci USA. 2015;112(18):5756–5761.
   PubMed Web of Science ®Google Scholar
• Ashbee HR, Barnes RA, Johnson EM, et al. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British society for medical mycology. J Antimicrob Chemother. 2014;69(5):1162–1176.
   PubMed Web of Science ®Google Scholar
• Nielsen SM, Kristensen L, Sondergaard A, et al. Increased prevalence and altered species composition of filamentous fungi in respiratory specimens from cystic fibrosis patients. APMIS. 2014;122(10):1007–1012.
   PubMed Web of Science ®Google Scholar
• Muller FM, Seidler M. Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis. Expert Rev Anti Infect Ther. 2010;8(8):957–964.
   PubMed Web of Science ®Google Scholar
• Shoseyov D, Brownlee KG, Conway SP, et al. Aspergillus bronchitis in cystic fibrosis. Chest. 2006;130(1):222–226.
   PubMed Web of Science ®Google Scholar
• Jones AM, Horsley A, Denning DW. What is the importance of classifying Aspergillus disease in cystic fibrosis patients? Expert Rev Respir Med. 2014;8(4):389–392.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Khan A, Aggarwal AN, et al. Link between CFTR mutations and ABPA: a systematic review and meta-analysis. Mycoses. 2012;55(4):357–365.
   PubMed Web of Science ®Google Scholar
• Bezerra GF, Gomes SM, Neto Silva MA, et al. Diversity and dynamics of airborne fungi in Sao Luis, State of Maranhao, Brazil. Rev Soc Bras Med Trop. 2014;47(1):69–73.
   PubMed Web of Science ®Google Scholar
• Rangaswamy B, Francis F, Prakash K, et al. Variability in airborne bacterial and fungal population in the tertiary health care centre. Aerobiologia. 2013;29(4):473–479.
   Web of Science ®Google Scholar
• Kanamori H, Rutala WA, Sickbert-Bennett EE, et al. Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation. Clin Infect Dis. 2015;61(3):433–444.
   PubMed Web of Science ®Google Scholar
• Alshareef F, Robson GD. Prevalence, persistence, and phenotypic variation of Aspergillus fumigatus in the outdoor environment in Manchester, UK, over a 2-year period. Med Mycol. 2014;52(4):367–375.
   PubMed Web of Science ®Google Scholar
• Paugam A, Baixench MT, Demazes-Dufeu N, et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol. 2010;48(Suppl 1):S32–S36.
   PubMed Web of Science ®Google Scholar
• Morio F, Horeau-Langlard D, Gay-Andrieu F, et al. Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol. 2010;48(5):1978–1982.
   PubMed Web of Science ®Google Scholar
• Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008;21(1):157–197.
   PubMed Web of Science ®Google Scholar
• Chmiel JF, Aksamit TR, Chotirmall SH, et al. Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. Ann Am Thorac Soc. 2014;11(8):1298–1306.
   PubMedGoogle Scholar
• Heltshe SL, Mayer-Hamblett N, Burns JL, et al. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor. Clin Infect Dis. 2015;60(5):703–712.
   PubMed Web of Science ®Google Scholar
• Ullrich G, Wiedau S, Schulz W, et al. Parental knowledge and behaviour to prevent environmental P. aeruginosa acquisition in their children with CF. J Cyst Fibros. 2008;7(3):231–237.
   PubMed Web of Science ®Google Scholar
• Ullrich G, Wiedau-Gors S, Steinkamp G, et al. Parental fears of Pseudomonas infection and measures to prevent its acquisition. J Cyst Fibros. 2002;1(3):122–130.
   PubMedGoogle Scholar
• Ashavaid TF, Raghavan R, Dhairyawan P, et al. Cystic fibrosis in India: a systematic review. J Assoc Physicians India. 2012;60:39–41.
   PubMedGoogle Scholar
• Naguib ML, Schrijver I, Gardner P, et al. Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis. J Cyst Fibros. 2007;6(2):111–116.
   PubMed Web of Science ®Google Scholar
• Kabra SK, Kabra M, Shastri S, et al. Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev. 2006;7(Suppl 1):S147–S150.
   PubMed Web of Science ®Google Scholar
• Scurati-Manzoni E, Fossali EF, Agostoni C, et al. Electrolyte abnormalities in cystic fibrosis: systematic review of the literature. Pediatr Nephrol. 2014;29(6):1015–1023.
   PubMed Web of Science ®Google Scholar
• Demaio AR, Rockstrom J. Human and planetary health: towards a common language. Lancet. 2015;386(10007):e36–e37.
   PubMed Web of Science ®Google Scholar